Neopterin: A Promising Candidate Biomarker for Severe COVID-19
Wasihun Hailemichael,1 Mulugeta Kiros,2 Yibeltal Akelew,3 Sisay Getu,4 Henok Andualem1 1Immunology and Molecular Biology, Medical Laboratory Science, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia; 2Medical Microbiology, Medical Laboratory Science, College of Health Scienc...
Guardado en:
Autores principales: | Hailemichael W, Kiros M, Akelew Y, Getu S, Andualem H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c6e1a711221f4865af1cd74103f9b59d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients
por: Alaiya A, et al.
Publicado: (2021) -
Distinct Patterns of Blood Cytokines Beyond a Cytokine Storm Predict Mortality in COVID-19
por: Herr C, et al.
Publicado: (2021) -
Hypercytokinemia and Pathogen–Host Interaction in COVID-19
por: Badawi A
Publicado: (2020) -
Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study
por: Zarębska-Michaluk D, et al.
Publicado: (2021) -
CORRELATION OF NEOPTERINE AND IFNγ LEVELS IN THE PATIENTS WITH EXACERBATION OF CHRONIC PERIODONTITIS AND INTOLERANCE OF DENTAL MATERIALS
por: I. Yu. Karpuk
Publicado: (2017)